etidronate has been researched along with Atheroma in 6 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty-seven patients with hypercholesterolemia were assigned to the atorvastatin (ATR)+etidronate (ETD) group (n = 45) or ATR group (n = 42)." | 3.77 | Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging. ( Furusawa, T; Inazu, T; Kawahara, T; Nishikawa, M; Suzuki, G, 2011) |
| "Statins are not effective in reducing atherosclerotic plaques of the abdominal aorta, and accumulating evidence suggests that bisphosphonates have the potential to induce the regression of atherosclerotic plaques of the abdominal aorta." | 2.78 | Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial. ( Inazu, T; Kawahara, C; Kawahara, T; Nishikawa, M; Sakai, K; Suzuki, G, 2013) |
| "Vascular calcification is an active process in which vascular smooth muscle cells (VSMCs) adopt an osteoblastic phenotype and deposit hydroxyapatite crystals; apoptosis of VSMCs also promotes this deposition." | 2.50 | The molecular biology and pathophysiology of vascular calcification. ( DiNicolantonio, JJ; McCarty, MF, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawahara, T | 3 |
| Nishikawa, M | 2 |
| Kawahara, C | 1 |
| Inazu, T | 2 |
| Sakai, K | 1 |
| Suzuki, G | 3 |
| King, A | 1 |
| McCarty, MF | 1 |
| DiNicolantonio, JJ | 1 |
| Scharlach, C | 1 |
| Kratz, H | 1 |
| Wiekhorst, F | 1 |
| Warmuth, C | 1 |
| Schnorr, J | 1 |
| Genter, G | 1 |
| Ebert, M | 1 |
| Mueller, S | 1 |
| Schellenberger, E | 1 |
| Furusawa, T | 1 |
1 review available for etidronate and Atheroma
| Article | Year |
|---|---|
The molecular biology and pathophysiology of vascular calcification.
Topics: Antioxidants; Biomarkers; Bone Density Conservation Agents; Etidronic Acid; Humans; Magnesium; Muscl | 2014 |
2 trials available for etidronate and Atheroma
| Article | Year |
|---|---|
Atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Atorvastatin; Bo | 2013 |
[Series: Clinical study from Japan and its reflections; atorvastatin, etidronate, or both in patients at high risk for atherosclerotic aortic plaques: a randomized, controlled trial].
Topics: Adult; Aged; Aged, 80 and over; Aorta; Atorvastatin; Drug Therapy, Combination; Etidronic Acid; Fema | 2014 |
3 other studies available for etidronate and Atheroma
| Article | Year |
|---|---|
Vascular disease: aortic plaque--dual therapy for a heterogeneous disease.
Topics: Aortic Diseases; Calcinosis; Etidronic Acid; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl- | 2013 |
Synthesis of acid-stabilized iron oxide nanoparticles and comparison for targeting atherosclerotic plaques: evaluation by MRI, quantitative MPS, and TEM alternative to ambiguous Prussian blue iron staining.
Topics: Animals; Aorta; Apolipoproteins E; Carotid Arteries; Citric Acid; Etidronic Acid; Ferric Compounds; | 2015 |
Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging.
Topics: Aorta; Atorvastatin; Bone Density Conservation Agents; Drug Therapy, Combination; Etidronic Acid; Fe | 2011 |